HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolidinesSofpironium
Chemical structure of CAS 1628251-49-9

Sofpironium

CAS No.1628251-49-9
MDL No.N/A
MFC22H32NO5+
MW390.50
InChI KeySEVCTUCCZYBJER-BSJAROSPSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1628251-49-9
Product NameSofpironium

Biological Targets

CHRM3·CHRM4·CHRM1·CHRM2·CHRM5

Associated Conditions

Hyperhidrosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

The Journal of dermatology • Vol. 48, Issue 8 • 2021
PMID: 34041788PMC: PMC8453842DOI: 10.1111/1346-8138.15927

A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

The Journal of dermatology • Vol. 48, Issue 3 • 2021
PMID: 33410265PMC: PMC7986147DOI: 10.1111/1346-8138.15668

Sofpironium Bromide: First Approval.

Drugs • Vol. 80, Issue 18 • 2020
PMID: 33236266DOI: 10.1007/s40265-020-01438-1

Documentation

Similar Products